Aria Diagnostics Seals $52.7M Series C
Molecular diagnostics company Aria Diagnostics has secured $52.7 million in Series C financing, the company announced Monday. Investors include Meritech Capital Partners, Venrock and Domain Associates. The company is developing cell-free DNA analysis technology for prenatal tests. The company is based in San Jose, Calif.
9 January 2012•2 mins read
